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Abstract
Background: Large repositories of biomedical research data are most useful to translational
researchers if their data can be aggregated for efficient queries and analyses. However, inconsistent
or non-existent annotations describing important sample details such as name of tissue or cell line,
histopathological type, and subject characteristics like demographics, treatment, and survival are
seldom present in data repositories, making it difficult to aggregate data.
Results: We created a flexible software tool that allows efficient annotation of samples using a
controlled vocabulary, and report on its use for the annotation of over 12,500 samples.
Conclusion: While the amount of data is very large and seemingly poorly annotated, a lot of
information is still within reach. Consistent tool-based re-annotation enables many new
possibilities for large scale interpretation and analyses that would otherwise be impossible.
Background
Quantitative gene expression experiments provide key
information for elucidating biological pathways and
understanding diseases. Many methods have been
developed over time, from hybridization based, North-
ern blotting, real-time polymerase chain reaction, high
throughput microarrays and serial analysis of gene
expression (SAGE), up to modern synthesis based
sequencing methods (454, ABI/SOLiD, Illumina/
Solexa). Microarrays are a popular technology for large-
scale measurement of gene expression. Substantial
public repositories have been set up to capture the
wealth of information on gene expression generated by
researchers world-wide: the National Center for Biotech-
nology Information’s Gene Expression Omnibus (GEO)
[1], the European Bioinformatics Institute’sA r r a y E x p r e s s
[2] and the DNA Data Bank of Japan’sC e n t e rf o r
Information Biology Gene Expression Database (CIBEX)
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Open Access[3]. There are, however, several essential pieces of
information that are needed to make these measure-
ments useful for anyone other than the original
researcher. First, a clear description of the process is
necessary to make results reproducible: This includes
description of the sample preparation, microarray plat-
form and reporter (probe) sequences. The second
essential piece of information is a description of the
data processing methods, from the raw image to the
expression level. Both steps have been subject to rigorous
standardization efforts in the past [4-6]. While it is still
challenging to compare measurements, another essential
piece of information has received far less attention:
Clinical data describing the origin and characteristics of
the samples, which is often sparse, inconsistent or
simply absent.
Due to the public availability of large microarray
repositories and reasonable standardization of measure-
ment values, many ‘meta-analyses’ and meta-analysis
systems emerged [7,8]. These approaches usually merged
the lists of differentially expressed genes obtained from
previous studies. While this led to emphasis and
validation of former results, new insights were less
frequent. In order to derive genuinely new results from
previous experiments, utilization of raw measurement
values is almost inevitable.
However, analysing the raw data is challenging, as it
requires (1) consistent and high quality probe annota-
tions for all involved platforms, (2) appropriate cross-
platform normalization methods, and (3) detailed
sample annotations. Only few were able to report
success with this approach [9]. While mapping reporter
sequences to genes no longer poses a problem, with high
quality gene transcripts and several updated re-mappings
at hand, normalization is more difficult, as many
different factors come into play [10]. Furthermore,
sample annotations in popular large collections are
hardly structured or consistent across studies and often
lack important details.
We addressed the problem of annotating gene expression
samples with a consistent set of variables on a large
number of existing studies. While this seems to be a
daunting task, there were sufficient similarities between
samples to make it possible to annotate many samples at
once. Moreover, we hypothesized that it was possible to
obtain high quality annotations by non-expert indivi-
duals who received proper training.
Previous manual or automatic annotation attempts
relied or tried to rely on domain experts to do the
annotation [11], which was costly and time consuming.
However, it has also been shown previously that using
students for annotation is a worthwhile alternative to
employing experts [12] and that the students themselves
quickly become experts for annotating a certain disease.
We were confident that students could become adept for
the task of annotating a specific set of variables in a
specific field.
In the past, several groups proposed annotation tools for
microarray experiments [13-18]. These approaches tried
to either automatically standardize the existing informa-
tion or create collaborative platforms together with
controlled vocabularies or ontologies to manually create
consistent and reusable sample annotations. While there
have been some successful cases of automatic term
normalization in a smaller scale [11], attempts to
automatically curate GEO, the largest public repository,
were of limited success, especially when expecting
detailed clinical annotation [19]. The large diversity of
information and unguided annotation currently present
in large repositories call for taking the best ideas from
these previous approaches and combining them into a
new tool.
Results and discussion
Our database currently contains the 45 most popular
platforms from GEO, 2,445 studies, and 58,432 samples.
We also imported a total of 1.6 billion raw measurement
values that can be used for new analyses with the help of
a cross-platform probe annotation and a cross-platform
normalization tool.
We were able to efficiently annotate more than 12,500
samples. More than half of these samples have been
redundantly annotated by at least two different annota-
tors. Within four weeks of work of one full time and one
part time annotator and a following five weeks of work
with four full time annotators, a total of almost half a
million variable assignments were made. On average,
every sample received 32 annotations.
The most frequently available variables were ‘tissue’ with
24,602 assignments, followed by ‘disease state’ with
12,098 annotations, ‘sample type’ with 9,792 annota-
tions, and ‘cell line’ with 11,925. Information about
genetic modification is also readily available in 11,135
annotations. Other frequently available variables were
‘treatment’, ‘time series’, ‘gender’, ‘patient age’, ‘lympha-
tic spread’, ‘estrogen receptor status’ and ‘tumor type’.
Conclusion
Many possibilities of further processing are within reach
with a method at hand that facilitates an efficient and
rich annotation of existing gene expression data. One
obvious use case is the regrouping of existing samples to
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the public repositories so the uploaded data is annotated
by the original submitter.
The potential benefit of these detailed annotations is
clear: While finding a suitable set of samples across
studies was virtually impossible using existing unstruc-
tured information alone, we are now able to easily find
and compare, for example, 4,405 breast cancer samples
with 473 normal breast samples, or 2052 ER+ versus 284
ER- samples. Figure 1 shows a screenshot from the
Annotation Explorer interface that uses the annotated
and normalized samples to compare gene expression
of BRCA1 across several annotated disease states. In
a future version, the annotated variables will be
made available in an ontology browser to allow for
more powerful searching, by expanding the concepts’
associations.
We have shown the feasibility of collecting publicly
available information about previous microarray experi-
ments and subjecting them to a consistent and efficient
annotation. With the current speed and quality of
annotation and a total of ten full-time annotators we
project the time to annotate all of GEO (currently almost
250,000 samples) with two redundant annotations per
sample to be 50 weeks. In the future, we plan to
assemble new large datasets and perform new differen-
tial expression analyses, avoiding the high cost of sample
collection, preparation and hybridization by exploiting
existing data.
Methods
The annotation process started with the identification of
possible studies for a certain disease by doing a keyword
search. This search yielded a list of studies that had the
keyword somewhere in their description or in the
description of their samples. Then, annotators proceeded
study by study, looking through available information in
the local database and following publication links and
their respective supplements. After going through all this
information, the annotators usually had a good idea of
what kind of samples they would subsequently be
looking at. Armed with this, they proceeded sample by
sample through each study.
Most of the annotation was conducted by one graduate
and three senior biology students. An initial pilot
annotation was done by one senior biology student
and a physician. From this pilot annotation we obtained
a feasible set of variables for large scale annotation. In a
separate report [20] we provide more details about the
quality of the annotation.
Import and structuring
The first step towards structured annotation was import-
ing large parts of GEO into a relational database by
parsing the SOFT files [21]. While these files all have the
same format and lexical structure, the individual study
and sample annotations contained therein differed
greatly in depth and presentation. We developed a tool
that makes it easy to import these files. We mapped
section names into a consistent scheme and filtered out
poorly annotated sections. We found many examples of
poor annotation. Some samples merely contained the
compulsory organism and source fields but left out other
essential information. Around 25% of the imported
samples had descriptions shorter than 30 characters, and
many just contained words like ‘NA’, ‘null’,t h eo r g a no r
a cryptic identifier.
Our database has a straightforward structure and
captures just the essentials, like title, description, and
organism for sample and studies. This information is the
same for all popular expression databases like Array-
Express or CIBEX, and the importer can be adapted to
pull data from these sources.
We created a custom web front-end that showed the
most consistently present fields and linked back to the
original GEO entries. This web-platform was subse-
quently extended as a platform for uniform sample
annotation. Moreover, we re-annotated probe-to-gene
mappings of most of our 45 locally available microarray
platforms using AceView [22] as a universal reference.
We have created an automatic microarray annotation
Figure 1
Screenshot of annotation explorer.A l lp r o b e sh a v e
been re-annotated to the AceView transcript database [22]
and normalized using a modified version of quantile
normalization [23] that has been adapted for very large
datasets. The screenshot shows the distribution of
normalized measurement values of BRCA1 for different
disease states.
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database that will be published soon.
Annotation system
One of the major difficulties was finding suitable
variables that were frequently available and uniquely
iden-tified concepts, while keeping the number of
variables low. A concise and complex medical nomen-
clature had to be clearly separated into distinct terms and
predefined choices, enabling non-expert annotators to
comprehend existing descriptions and correctly label the
described samples.
T h eu n d e r l y i n gi d e ao ft h ea n n o t a t i o ns y s t e mw a st o
freely attach variables to samples, allowing any variable
to be used for any sample. New variables could also be
created and assigned if necessary. However, after the
initial pilot study, a predefined set of variables with a
predefined range of values was established for every
disease through discussion and evaluation by experts.
This encouraged consistent use of variables and values
while at the same providing some freedom to capture
seemingly important additional information. To further
promote consistency between annotators, newly created
variables and non-predefined values were visible to all
annotators, albeit less prominently displayed than
predefined variables in order to avoid cluttering the
interface. This helped us keep a consistent naming
scheme even for less important variables in case this
information was also available. This guided yet flexible
system proved extremely useful as we extended our
annotation efforts to cover more diseases.
To facilitate faster annotation of frequently used values,
new values could later be added to the set of predefined
values and were then directly visible. Predefined vari-
ables were grouped into the categories ‘essential’,
‘patient’, ‘treatment’,a n d‘sample’.V a r i a b l e sw e r ec a t e -
gorized according to individual diseases they appeared
i n .S of a rw ec r e a t e dt h e s es e t sof variables and annotated
samples for breast cancer, colon cancer, insulin depen-
dent diabetes mellitus, rheumatoid arthritis and systemic
lupus erythematosus.
Definition of new variables and possible values is
performed using a text format. After review, these are
added into the active list of variables by running a script
on the text file. This way it is also possible to create new
annotation forms that consist of existing variables using
the variable definition format shown in Table 1.
Annotation tool
We built a web-based annotation platform to collabora-
tively create sample annotations in our expression
database. Figure 2 shows several useful features of this
platform. On the left side, the screenshot shows the
study view. All samples and studies are linked back to
their original entries within the original repository. Our
database contains the titles and summaries of studies
and samples which are usually the titles and abstracts of
the corresponding publication. The publication itself can
be obtained by following a link to the PubMed database.
Previous annotations of studies, called GEO datasets
(GDS) provided a grouping of samples. Unfortunately,
these annotations were available in only 20% of the
cases and provide only a group distinction in one
variable. Another way for annotators to find similar
samples within one study was by searching for sample
title, description, source, GDS annotation text or
previous annotations in our system. Several samples
could be selected for multi-sample annotation. In the
multi-sample annotation form (not shown) the selected
annotation was performed for all selected samples at
once. It contained a summary for each of the samples
and the same annotation interface as for single sample
annotation. In addition, all annotations from one
sample could be copied to another sample within the
web application. At the very bottom of the study view
page (not shown in the screenshots), a large text area
captured any additional useful information the annota-
tors wanted to collect.
The right side of Figure 2 shows the sample annotation
interface: After the local information for each sample was
displayed (not shown in screenshot), a form with all
predefined variables and values prompted for annota-
tion. Variables, that had already been filled out, did not
show up again for the same user. Below the initial
section with predefined variables and values the anno-
tator could find a powerful free-form annotation tool
that allowed users to find and assign any variable that
had previously been used, regardless of whether it was
originally predefined or not. It also enabled the
annotators to create new variables or assign new values
to variables that did not allow free text. This feature
proved to be useful in the pilot phase of annotation for a
new disease, when it was still uncertain what informa-
tion would be available. Further below, existing
Table 1: Variable definition file
Colon Cancer : Patient : *age
Colon Cancer : Sample : *genetically modified
Colon Cancer : Sample : *tumor size
Colon Cancer : Essential : tissue, normal, benign, cancerous, non-colon
This example shows the definition of a small annotation form Colon
Cancer with the two groups Patient and Sample that contain the variables
age, genetically modified and tumor size which reference previously
defined variables and one new variable tissue with the predefined
choices normal, benign, cancerous and non-colon.
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assigned value, the author of the annotation, and the
number of times the variable had been used for every
variable assignment. If the annotated value was one of
the predefined values for a certain variable, it was
highlighted in green.
T h ei n t e r n a lf o r m a to ft h ea n n o t a t i o n sw a sal i s to f
tuples of the form (sample id, variable id, value)i n s i d eo u r
relational database that can be used to check for
concordant annotations, extract samples with certain
properties and their associated gene expression values.
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